J. Tami

506 total citations
8 papers, 397 citations indexed

About

J. Tami is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, J. Tami has authored 8 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Genetics. Recurrent topics in J. Tami's work include Cell Adhesion Molecules Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Inflammatory Bowel Disease (3 papers). J. Tami is often cited by papers focused on Cell Adhesion Molecules Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Inflammatory Bowel Disease (3 papers). J. Tami collaborates with scholars based in United States, France and Canada. J. Tami's co-authors include Thompson Js, Bruce Yacyshyn, Rosie Z. Yu, J S Goff, William Shanahan, Ekaterina Gibiansky, Alan L. Buchman, Bruce Salzberg, W. Y. Chey and K. Lea Sewell and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and Gut.

In The Last Decade

J. Tami

8 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Tami United States	7	167	144	95	86	65	8	397
R Khiroya United States	11	135 0.8×	271 1.9×	137 1.4×	49 0.6×	105 1.6×	14	502
Stany Depraetere Belgium	9	37 0.2×	178 1.2×	77 0.8×	87 1.0×	33 0.5×	13	404
Werner Vogetseder Austria	11	41 0.2×	184 1.3×	127 1.3×	76 0.9×	74 1.1×	19	448
Carole Kurahara United States	10	129 0.8×	390 2.7×	180 1.9×	64 0.7×	91 1.4×	12	682
A Salerno Italy	16	41 0.2×	264 1.8×	94 1.0×	80 0.9×	50 0.8×	41	575
Mark T. Scherer United States	8	83 0.5×	491 3.4×	128 1.3×	66 0.8×	106 1.6×	10	656
Louis J. Rezanka United States	12	144 0.9×	265 1.8×	143 1.5×	87 1.0×	46 0.7×	17	557
M. Simon Slovakia	13	53 0.3×	84 0.6×	86 0.9×	103 1.2×	21 0.3×	45	419
Klaus Drexler Germany	12	129 0.8×	212 1.5×	120 1.3×	45 0.5×	73 1.1×	14	446
Linda M. Karavodin United States	12	88 0.5×	240 1.7×	170 1.8×	88 1.0×	129 2.0×	18	556

Countries citing papers authored by J. Tami

Since Specialization

Citations

This map shows the geographic impact of J. Tami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Tami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Tami more than expected).

Fields of papers citing papers by J. Tami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Tami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Tami. The network helps show where J. Tami may publish in the future.

Co-authorship network of co-authors of J. Tami

This figure shows the co-authorship network connecting the top 25 collaborators of J. Tami. A scholar is included among the top collaborators of J. Tami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Tami. J. Tami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Yacyshyn, Bruce, et al.. (2005). Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1. Clinical & Experimental Immunology. 141(1). 141–147. 8 indexed citations

2.

Yacyshyn, Bruce, Charles F. Barish, J S Goff, et al.. (2002). Dose ranging pharmacokinetic trial of high‐dose alicaforsen (intercellular adhesion molecule‐1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease. Alimentary Pharmacology & Therapeutics. 16(10). 1761–1770. 55 indexed citations

3.

Yacyshyn, Bruce, W. Y. Chey, J S Goff, et al.. (2002). Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease. Gut. 51(1). 30–36. 166 indexed citations

4.

Yacyshyn, Bruce, et al.. (1998). Sefety of retreatment with antisense to icam-1 (isis 2302) in patients with steroid-dependent Crohn's disease. Gastroenterology. 114. A1118–A1118. 1 indexed citations

5.

Infante, A J, Paola Infante, Celia Jackson, et al.. (1996). Evidence against chronic antigen-specific T lymphocyte activation in myasthenia gravis. Journal of Neuroscience Research. 45(4). 492–499. 7 indexed citations

6.

Morstyn, George, John A. Glaspy, Elizabeth J. Shpall, et al.. (1994). Clinical Applications of Filgrastim and Stem Cell Factor In Vivo and In Vitro. Journal of Hematotherapy. 3(4). 353–355. 6 indexed citations

7.

Tami, J., et al.. (1987). T cell hybridomas reactive with the acetylcholine receptor and its subunits.. The Journal of Immunology. 138(3). 732–738. 16 indexed citations

8.

Tami, J., et al.. (1986). Monoclonal antibody technology.. PubMed. 43(11). 2816–25. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact